Cargando…

Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study

OBJECTIVE: To analyse the association of faecal calprotectin with the genetic and clinical characteristics of paediatric patients with cystic fibrosis (PwCF). In a subset of these patients, we aimed to associate histological inflammatory features of rectal mucosa to faecal calprotectin levels. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Roda, Juliana, Maia, Carla, Almeida, Susana, Oliveira, Rui Caetano, Ferreira, Ricardo, Oliveira, Guiomar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058793/
https://www.ncbi.nlm.nih.gov/pubmed/36053631
http://dx.doi.org/10.1136/bmjpo-2022-001422
_version_ 1784698189504315392
author Roda, Juliana
Maia, Carla
Almeida, Susana
Oliveira, Rui Caetano
Ferreira, Ricardo
Oliveira, Guiomar
author_facet Roda, Juliana
Maia, Carla
Almeida, Susana
Oliveira, Rui Caetano
Ferreira, Ricardo
Oliveira, Guiomar
author_sort Roda, Juliana
collection PubMed
description OBJECTIVE: To analyse the association of faecal calprotectin with the genetic and clinical characteristics of paediatric patients with cystic fibrosis (PwCF). In a subset of these patients, we aimed to associate histological inflammatory features of rectal mucosa to faecal calprotectin levels. METHODS: In a prospective study, faecal calprotectin levels were collected in all 23 PwCF attending our paediatric centre, together with demographic and clinical data. Associations between faecal calprotectin and clinical features were determined. In 11 of these patients, endoscopic rectal biopsies were obtained and the association between faecal calprotectin and histological inflammatory markers was analysed. Statistical analyses included Spearman’s correlation coefficient, Mann-Whitney U test and Fisher’s exact test. Sensitivity and specificity was calculated. RESULTS: Median age of PwCF was 12 years, 19 had pancreatic insufficiency (PI) (19/23). Seventeen (17/23) had elevated faecal calprotectin, and the median value was 88 µg/g (IQR=178 µg/g). Higher faecal calprotectin levels were observed in the PI group (101 vs 30 µg/g, p=0.027). No significant correlation between elevated faecal calprotectin level and body mass index z-score was found. Five patients (22%) reported abdominal pain, three (13%) complained of diarrhoea and three (13%) had constipation, but these symptoms were not associated with elevated faecal calprotectin. Unspecific focal rectal inflammation was found in four patients (4/11). An association between rectal mucosa inflammation and elevated faecal calprotectin was found (p=0.015). Sensitivity was 100% and specificity was 86%. CONCLUSIONS: In our PwCF, elevated faecal calprotectin was frequent, particularly if PI, and it was not related to gastrointestinal symptoms or malnutrition. Elevated faecal calprotectin was present in patients with histological evidence of rectal inflammation. Faecal calprotectin may be an indicator of asymptomatic rectal inflammation in PwCF.
format Online
Article
Text
id pubmed-9058793
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-90587932022-05-12 Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study Roda, Juliana Maia, Carla Almeida, Susana Oliveira, Rui Caetano Ferreira, Ricardo Oliveira, Guiomar BMJ Paediatr Open Gastroenterology OBJECTIVE: To analyse the association of faecal calprotectin with the genetic and clinical characteristics of paediatric patients with cystic fibrosis (PwCF). In a subset of these patients, we aimed to associate histological inflammatory features of rectal mucosa to faecal calprotectin levels. METHODS: In a prospective study, faecal calprotectin levels were collected in all 23 PwCF attending our paediatric centre, together with demographic and clinical data. Associations between faecal calprotectin and clinical features were determined. In 11 of these patients, endoscopic rectal biopsies were obtained and the association between faecal calprotectin and histological inflammatory markers was analysed. Statistical analyses included Spearman’s correlation coefficient, Mann-Whitney U test and Fisher’s exact test. Sensitivity and specificity was calculated. RESULTS: Median age of PwCF was 12 years, 19 had pancreatic insufficiency (PI) (19/23). Seventeen (17/23) had elevated faecal calprotectin, and the median value was 88 µg/g (IQR=178 µg/g). Higher faecal calprotectin levels were observed in the PI group (101 vs 30 µg/g, p=0.027). No significant correlation between elevated faecal calprotectin level and body mass index z-score was found. Five patients (22%) reported abdominal pain, three (13%) complained of diarrhoea and three (13%) had constipation, but these symptoms were not associated with elevated faecal calprotectin. Unspecific focal rectal inflammation was found in four patients (4/11). An association between rectal mucosa inflammation and elevated faecal calprotectin was found (p=0.015). Sensitivity was 100% and specificity was 86%. CONCLUSIONS: In our PwCF, elevated faecal calprotectin was frequent, particularly if PI, and it was not related to gastrointestinal symptoms or malnutrition. Elevated faecal calprotectin was present in patients with histological evidence of rectal inflammation. Faecal calprotectin may be an indicator of asymptomatic rectal inflammation in PwCF. BMJ Publishing Group 2022-04-28 /pmc/articles/PMC9058793/ /pubmed/36053631 http://dx.doi.org/10.1136/bmjpo-2022-001422 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Gastroenterology
Roda, Juliana
Maia, Carla
Almeida, Susana
Oliveira, Rui Caetano
Ferreira, Ricardo
Oliveira, Guiomar
Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study
title Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study
title_full Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study
title_fullStr Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study
title_full_unstemmed Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study
title_short Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study
title_sort faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study
topic Gastroenterology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058793/
https://www.ncbi.nlm.nih.gov/pubmed/36053631
http://dx.doi.org/10.1136/bmjpo-2022-001422
work_keys_str_mv AT rodajuliana faecalcalprotectinandrectalhistologicalinflammatorymarkersincysticfibrosisasinglecentrestudy
AT maiacarla faecalcalprotectinandrectalhistologicalinflammatorymarkersincysticfibrosisasinglecentrestudy
AT almeidasusana faecalcalprotectinandrectalhistologicalinflammatorymarkersincysticfibrosisasinglecentrestudy
AT oliveiraruicaetano faecalcalprotectinandrectalhistologicalinflammatorymarkersincysticfibrosisasinglecentrestudy
AT ferreiraricardo faecalcalprotectinandrectalhistologicalinflammatorymarkersincysticfibrosisasinglecentrestudy
AT oliveiraguiomar faecalcalprotectinandrectalhistologicalinflammatorymarkersincysticfibrosisasinglecentrestudy